Hyperphenylalaninemia

From WikiMD's medical encyclopedia

(Redirected from Maternal hyperphenylalaninemia)

Dr.Prab.jpg

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Hyperphenylalaninemia
Autosomal recessive - en.svg
Synonyms HPA
Pronounce N/A
Specialty N/A
Symptoms Elevated levels of phenylalanine in the blood
Complications Intellectual disability, seizures, behavioral problems
Onset Neonatal
Duration Lifelong
Types N/A
Causes Genetic mutation in the PAH gene
Risks Family history of the condition
Diagnosis Newborn screening, blood test
Differential diagnosis Phenylketonuria, biopterin deficiency
Prevention None
Treatment Dietary management, phenylalanine-restricted diet
Medication Sapropterin, pegvaliase
Prognosis Good with early treatment
Frequency 1 in 10,000 to 15,000 newborns
Deaths N/A


Hyperphenylalaninemia is a metabolic disorder characterized by elevated levels of the amino acid phenylalanine in the blood. Phenylalanine is a building block of proteins that is obtained through the diet, primarily from protein-containing foods. In individuals with hyperphenylalaninemia, the metabolic process that converts phenylalanine into another amino acid, tyrosine, is impaired, leading to an accumulation of phenylalanine in the body. This condition can result from a variety of genetic and non-genetic causes, with the most severe form being Phenylketonuria (PKU).

Causes

Hyperphenylalaninemia can be caused by mutations in several genes, with the most common being mutations in the PAH gene, which encodes the enzyme phenylalanine hydroxylase. This enzyme is crucial for the normal metabolism of phenylalanine. Deficiencies in this enzyme lead to varying degrees of hyperphenylalaninemia, depending on the specific mutation and its effect on enzyme activity. Other less common causes include deficiencies in the enzymes or cofactors involved in the metabolic pathway downstream of phenylalanine hydroxylase.

Classification

Hyperphenylalaninemia is classified based on the blood phenylalanine levels and the underlying cause. The most severe form is Phenylketonuria (PKU), which is characterized by very high levels of phenylalanine and is caused by a near-total deficiency of phenylalanine hydroxylase activity. Milder forms of hyperphenylalaninemia result from partial deficiencies of this enzyme or from defects in the synthesis or recycling of tetrahydrobiopterin (BH4), a cofactor necessary for the enzyme's activity.

Symptoms

The symptoms of hyperphenylalaninemia vary depending on the severity of the condition. In severe cases, such as untreated PKU, symptoms can include intellectual disability, behavioral problems, seizures, and a musty odor in the breath, skin, or urine due to the accumulation of phenylalanine and its byproducts. Milder forms of the condition may be asymptomatic or may only become apparent under conditions of stress or increased protein intake.

Diagnosis

Diagnosis of hyperphenylalaninemia typically involves newborn screening, which can detect elevated levels of phenylalanine in the blood. Confirmatory tests, including genetic testing and enzyme activity assays, may be performed to determine the specific type and cause of hyperphenylalaninemia.

Treatment

The treatment of hyperphenylalaninemia depends on its cause and severity. Dietary management is the mainstay of treatment for most forms of the condition. This involves a diet low in phenylalanine, which helps to prevent the accumulation of this amino acid and its toxic byproducts. For individuals with PKU, a synthetic form of the enzyme that is deficient or a medication that enhances the residual activity of the enzyme may also be used. In some cases, treatment with sapropterin, a synthetic form of BH4, may be effective, particularly in individuals with hyperphenylalaninemia due to a deficiency in this cofactor.

Prognosis

With early diagnosis and appropriate treatment, individuals with hyperphenylalaninemia can lead healthy lives. However, untreated or poorly managed hyperphenylalaninemia can lead to severe intellectual and developmental disabilities.

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP-1 injections from $125.

W8mdlogo.png
W8MD weight loss doctors team

W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:

NYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Linkedin_Shiny_Icon Facebook_Shiny_Icon YouTube_icon_(2011-2013) Google plus


Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD